Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2025-12-24 @ 3:54 PM
NCT ID:
NCT00053092
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed previously untreated mantle cell lymphoma requiring therapy
* Any stage
PATIENT CHARACTERISTICS:
Age
* 18 and over
Performance status
* Not specified
Life expectancy
* At least 3 months
Hematopoietic
* Not specified
Hepatic
* Bilirubin no greater than 2.5 times upper limit of normal (ULN)\^\*
* Alkaline phosphatase no greater than 2.5 times ULN\^\*
* Hepatitis B and hepatitis C negative NOTE: \*Unless related to lymphoma
Renal
* Creatinine no greater than 2.5 times ULN\^\* NOTE: \*Unless related to lymphoma
Other
* No other malignancy within the past 5 years except non-melanoma skin cancer or curatively resected carcinoma in situ of the cervix
* No prior psychological illness or condition that would preclude study compliance
* No known hypersensitivity to murine proteins
* No concurrent uncontrolled medical conditions
* No other illness that would severely limit life expectancy
* HIV negative
* Not pregnant or nursing
* Negative pregnancy test
* Fertile patients must use effective contraception during and for 6 months after study participation
PRIOR CONCURRENT THERAPY:
Biologic therapy
* Not specified
Chemotherapy
* No prior chemotherapy
Endocrine therapy
* Not specified
Radiotherapy
* Not specified
Surgery
* Not specified
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00053092
Study Brief:
Protocol Section:
NCT00053092